So there is a nurse, who caught ebola in Africa and has been transported to the specialised quarantine unit in The Royal Free hospital in Hampstead, England, UK. This is a one of a kind set up in Europe, nowhere else has the specialist capacity to handle this type of possible pandemic, causative agent. What makes them different, is that there is no potential contact between the carrier and treatment provider, there is a physical plastic barrier of between the patient and the person administering the medicine, so there is little to no possibility of transmission.
Thankfully, there is one drug, ZMAPP, created by a US firm MAPP which possibly has a cure to the disease. To give a bit of background, in our increasingly globalised community, there is a real fear that a viral pandemic, such as the one occurring in Sub-Saharan Africa will quickly become a global epidemic, such as the Spanish Flu of 1918, which killed over 500 million+ people.
Governments around the globe, are increasingly worried about the emergence of regional pandemics potentially becoming global epidemics due to increased international migration. Therefore, global pharmaceutical firms, know the potential for governments to stockpile antiviral medicines to protect citizens, see Tamiflu stockpiling in 2006. Currently, the Japanese government is already stockpiling a drug which has not even been proven to cure Ebola, but it is stockpiling the medicine anyway, just in case of a global epidemic.
Who is up for betting that the nurse who has Ebola, which has a curative rate of over 90% in Western healthcare institutions, due to accessibility of antibiotics and rehydration, miraculously becomes cured, is then attributed to ZMAPP as a curative agent.
Keep an eye on whether the nurse survives and the share worth of MAPP Pharmaceuticals, it has already doubled in value since 2013...
**Update 20th September 2014**
So as predicted the nurse survived. On the back of this one high profile case ZMAPP has now been sold to GSK, for probably a lot of money and they are going to start mass producing it.
Thankfully, there is one drug, ZMAPP, created by a US firm MAPP which possibly has a cure to the disease. To give a bit of background, in our increasingly globalised community, there is a real fear that a viral pandemic, such as the one occurring in Sub-Saharan Africa will quickly become a global epidemic, such as the Spanish Flu of 1918, which killed over 500 million+ people.
Governments around the globe, are increasingly worried about the emergence of regional pandemics potentially becoming global epidemics due to increased international migration. Therefore, global pharmaceutical firms, know the potential for governments to stockpile antiviral medicines to protect citizens, see Tamiflu stockpiling in 2006. Currently, the Japanese government is already stockpiling a drug which has not even been proven to cure Ebola, but it is stockpiling the medicine anyway, just in case of a global epidemic.
Who is up for betting that the nurse who has Ebola, which has a curative rate of over 90% in Western healthcare institutions, due to accessibility of antibiotics and rehydration, miraculously becomes cured, is then attributed to ZMAPP as a curative agent.
Keep an eye on whether the nurse survives and the share worth of MAPP Pharmaceuticals, it has already doubled in value since 2013...
**Update 20th September 2014**
So as predicted the nurse survived. On the back of this one high profile case ZMAPP has now been sold to GSK, for probably a lot of money and they are going to start mass producing it.
No comments:
Post a Comment